Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders, Lymphoproliferative”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00176865
What this trial is testing

Stem Cell Transplant for Immunologic or Histiocytic Disorders

Who this might be right for
Hemophagocytic LymphohistiocytosisX-Linked Lymphoproliferative DisordersChediak-Higashi Syndrome+3 more
Masonic Cancer Center, University of Minnesota 19
Large-scale testing (Phase 3)Ended earlyNCT02417129
What this trial is testing

BI 695500 vs Rituxan First Line Treatment in Patients With Low Tumor Burden Follicular Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Boehringer Ingelheim 2
Testing effectiveness (Phase 2)Study completedNCT01058239
What this trial is testing

Bortezomib Plus Rituximab for EBV+ PTLD

Who this might be right for
Post-transplant Lymphoproliferative DiseaseSolid Organ TransplantStem Cell Transplant (Bone Marrow Transplant)+1 more
Massachusetts General Hospital 7
Not applicableLooking for participantsNCT03193892
What this trial is testing

A National Registry on Chinese Patients With Lymphangioleiomyomatosis

Who this might be right for
Pulmonary Function
Peking Union Medical College Hospital 1,500
Early research (Phase 1)Ended earlyNCT03015792
What this trial is testing

Ibrutinib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Ineligible for Transplant

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Mayo Clinic 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT04067336
What this trial is testing

First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Advanced Malignant NeoplasmAcute Myeloid LeukemiaMixed Lineage Leukemia+4 more
Kura Oncology, Inc. 263
Not applicableUnknownNCT05275036
What this trial is testing

Assessment of Early-detection Based on Liquid Biopsy in Lymphoid Malignancies

Who this might be right for
Lymphoma
Sun Yat-sen University 493
Testing effectiveness (Phase 2)Study completedNCT02208037
What this trial is testing

Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)

Who this might be right for
Acute LeukemiaChronic Myelogenous LeukemiaMyelodysplasia+6 more
National Heart, Lung, and Blood Institute (NHLBI) 279
Early research (Phase 1)Ended earlyNCT05660395
What this trial is testing

Evaluate the Pharmacokinetics and Safety of Loncastuximab Tesirine in Participants With Relapsed or Refractory Diffuse Large B-cell Lymphoma or High-grade B-cell Lymphoma With Hepatic Impairment (LOTIS-10)

Who this might be right for
Diffuse Large B-Cell LymphomaHigh-grade B-cell Lymphoma
ADC Therapeutics S.A. 5
Testing effectiveness (Phase 2)Looking for participantsNCT07519772
What this trial is testing

A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

Who this might be right for
Lymphoma, Non-HodgkinLymphoma, FollicularLymphoma, Large B-Cell, Diffuse
Merck Sharp & Dohme LLC 280
Testing effectiveness (Phase 2)Study completedNCT00101595
What this trial is testing

Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Who this might be right for
Chronic Myeloid LeukemiaLeukemia, Lymphoblastic, Acute, Philadelphia-positive
Bristol-Myers Squibb 96
Not applicableStudy completedNCT00252057
What this trial is testing

Testing the Re-Engineered Hospital Discharge

Who this might be right for
All
Boston University 749
Testing effectiveness (Phase 2)WithdrawnNCT06068881
What this trial is testing

Assess Efficacy and Safety of Oral Tazemetostat in Adult Participants With Relapsed/Refractory Follicular Lymphoma That Does Not Have an "EZH2 Gain-of-function" Genetic Mutation

Who this might be right for
Follicular LymphomaRefractory Follicular Lymphoma
Epizyme, Inc.
Testing effectiveness (Phase 2)Study completedNCT00309881
What this trial is testing

Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT)

Who this might be right for
Chronic Lymphocytic Leukemia
German CLL Study Group 75
Early research (Phase 1)Study completedNCT00049400
What this trial is testing

S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
SWOG Cancer Research Network 78
Early research (Phase 1)Study completedNCT03111992
What this trial is testing

Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Novartis Pharmaceuticals 26
Large-scale testing (Phase 3)Not Yet RecruitingNCT07178457
What this trial is testing

Brentuximab Vedotin in CutAneous T-cell Lymphomas (CTCL): Post-allogeneic Hematopoietic Stem Cell Transplant Maintenance

Who this might be right for
Cutaneous T Cell Lymphoma (CTCL)Brentuximab Vedotin
Assistance Publique - Hôpitaux de Paris 84
Post-approval studies (Phase 4)Study completedNCT06035757
What this trial is testing

The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery

Who this might be right for
Emergence DeliriumStrabismusPediatric ALL
Konkuk University Medical Center 76
Early research (Phase 1)Study completedNCT01231919
What this trial is testing

MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Study completedNCT01234467
What this trial is testing

Bendamustine + Rituximab in Older Patients With Previously Untreated Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-Cell LymphomaLymphoma, Diffuse Large-CellDiffuse Large-Cell Lymphoma+1 more
UNC Lineberger Comprehensive Cancer Center 23
Next Page